PacWest Financial Management’s Novartis NVS Stock Holding History

PacWest Financial Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.9M	Sell	5,976 -1,003	-14%	-$65.1K	0.23%	74
2016 Q3	$494K	Buy	6,979 +27	+0.4%	+$1.97K	0.3%	71
2016 Q2	$514K	Sell	6,952 -1,526	-18%	-$105K	0.32%	69
2016 Q1	$550K	Sell	8,478 -121	-1%	-$8.23K	0.35%	71
2015 Q4	$663K	Buy	8,599 +257	+3%	+$20.4K	0.44%	67
2015 Q3	$687K	Buy	8,342 +50	+0.6%	+$4.45K	0.51%	67
2015 Q2	$732K	Hold	8,292	–	–	0.52%	70
2015 Q1	$732K	Buy	8,292 +145	+2%	+$12.9K	0.52%	69
2014 Q4	$676K	Buy	8,147 +352	+5%	+$29.2K	0.48%	70
2014 Q3	$657K	Hold	7,795	–	–	0.49%	71
2014 Q2	$632K	Buy	7,795 +111	+1%	+$8.73K	0.47%	72
2014 Q1	$585K	Sell	7,684 -195	-2%	-$14.2K	0.45%	70
2013 Q4	$567	Buy	7,879 +112	+1%	+$7.79K	0.17%	71
2013 Q3	$534K	Hold	7,767	–	–	0.46%	66
2013 Q2	$492K	Buy	+7,767	New	+$505K	0.47%	66

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

PacWest Financial Management's NVS Position: Q4 2016 in Review

PacWest Financial Management reduced its Novartis (NVS) stake by 14% in Q4 2016, selling an estimated $65.1K and leaving 5,976 shares worth $3.9M. The position accounts for 0.23% of the portfolio, ranked #74.

PacWest Financial Management first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

PacWest Financial Management held 5,976 shares of Novartis worth $3.9M as of Q4 2016.
PacWest Financial Management sold 1,003 Novartis shares in Q4 2016, an estimated $65.1K.
Novartis made up 0.23% of PacWest Financial Management's portfolio in Q4 2016, its #74 holding.
PacWest Financial Management first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.